STUDY DESIGN: Prospective analysis of a consecutive cohort of adult spinal deformity patients queried over a 12-month period. OBJECTIVES: To assess the SRS-22 instrument compared with the SF-12 and Oswestry. SUMMARY OF BACKGROUND DATA: Very few reports in the literature have applied the SRS-22 to adult spinal deformity patients. METHODS: Consecutive adult spinal deformity patients were applied the SRS-22, SF-12, and Oswestry. Four analyses were done: 1) floor/ceiling effect; 2) Pearson's correlation coefficients between the SRS-22, SF-12, and Oswestry; 3) Cronbach's alpha analysis for internal consistency within the SRS-22; and 4) test/retest. RESULTS: Floor/ceiling range for the SRS-22 compared favorably with the SF-12 and Oswestry. The Pearson's coefficients correlating the two questionnaires relative to the SRS-22 were > 0.7. The Cronbach's alpha within each domain for the SRS-22 were > 0.7, except for pain (0.67). Test/retest correlation coefficients ranged from 0.84 to 0.95 for the subscales. CONCLUSIONS: The SRS-22 is a disease-specific instrument with the capacity to demonstrate change in health status more effectively than the SF-12 and in more domains than the Oswestry. The SRS-22 showed high criterion validity with the SF-12 and Oswestry based on Pearson's coefficients. High Cronbach's alpha scores suggested a high internal consistency within each domain of the SRS-22, except for pain (0.67). Test/retest reliability was excellent.
STUDY DESIGN: Prospective analysis of a consecutive cohort of adult spinal deformitypatients queried over a 12-month period. OBJECTIVES: To assess the SRS-22 instrument compared with the SF-12 and Oswestry. SUMMARY OF BACKGROUND DATA: Very few reports in the literature have applied the SRS-22 to adult spinal deformitypatients. METHODS: Consecutive adult spinal deformitypatients were applied the SRS-22, SF-12, and Oswestry. Four analyses were done: 1) floor/ceiling effect; 2) Pearson's correlation coefficients between the SRS-22, SF-12, and Oswestry; 3) Cronbach's alpha analysis for internal consistency within the SRS-22; and 4) test/retest. RESULTS: Floor/ceiling range for the SRS-22 compared favorably with the SF-12 and Oswestry. The Pearson's coefficients correlating the two questionnaires relative to the SRS-22 were > 0.7. The Cronbach's alpha within each domain for the SRS-22 were > 0.7, except for pain (0.67). Test/retest correlation coefficients ranged from 0.84 to 0.95 for the subscales. CONCLUSIONS: The SRS-22 is a disease-specific instrument with the capacity to demonstrate change in health status more effectively than the SF-12 and in more domains than the Oswestry. The SRS-22 showed high criterion validity with the SF-12 and Oswestry based on Pearson's coefficients. High Cronbach's alpha scores suggested a high internal consistency within each domain of the SRS-22, except for pain (0.67). Test/retest reliability was excellent.
Authors: Shian Liu; Frank Schwab; Justin S Smith; Eric Klineberg; Christopher P Ames; Gregory Mundis; Richard Hostin; Khaled Kebaish; Vedat Deviren; Munish Gupta; Oheneba Boachie-Adjei; Robert A Hart; Shay Bess; Virginie Lafage Journal: Ochsner J Date: 2014
Authors: Takashi Fujishiro; Louis Boissière; Derek Thomas Cawley; Daniel Larrieu; Olivier Gille; Jean-Marc Vital; Ferran Pellisé; Francisco Javier Sanchez Pérez-Grueso; Frank Kleinstück; Emre Acaroglu; Ahmet Alanay; Ibrahim Obeid Journal: Eur Spine J Date: 2019-03-07 Impact factor: 3.134
Authors: Takashi Fujishiro; Louis Boissière; Derek Thomas Cawley; Daniel Larrieu; Olivier Gille; Jean-Marc Vital; Ferran Pellisé; Francisco Javier Sanchez Pérez-Grueso; Frank Kleinstück; Emre Acaroglu; Ahmet Alanay; Ibrahim Obeid Journal: Eur Spine J Date: 2019-07-17 Impact factor: 3.134
Authors: Sayf S A Faraj; Miranda L van Hooff; Roderick M Holewijn; David W Polly; Tsjitske M Haanstra; Marinus de Kleuver Journal: Eur Spine J Date: 2017-05-22 Impact factor: 3.134
Authors: A F Mannion; A Vila-Casademunt; M Domingo-Sàbat; S Wunderlin; F Pellisé; J Bago; E Acaroglu; A Alanay; F S Pérez-Grueso; I Obeid; F S Kleinstück Journal: Eur Spine J Date: 2015-10-30 Impact factor: 3.134
Authors: James T Bennett; Amer F Samdani; Tracey P Bastrom; Robert J Ames; Firoz Miyanji; Joshua M Pahys; Michelle C Marks; Baron S Lonner; Peter O Newton; Harry L Shufflebarger; Burt Yaszay; John M Flynn; Randal R Betz; Patrick J Cahill Journal: Eur Spine J Date: 2016-12-09 Impact factor: 3.134
Authors: Steven L Bokshan; Jakub Godzik; Jonathan Dalton; Jennifer Jaffe; Lawrence G Lenke; Michael P Kelly Journal: Spine J Date: 2016-03-17 Impact factor: 4.166